6-31779043-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM2PP2BP4_Strong
The NM_006295.3(VARS1):c.3650G>A(p.Arg1217His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000143 in 1,612,670 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1217C) has been classified as Benign.
Frequency
Consequence
NM_006295.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VARS1 | NM_006295.3 | c.3650G>A | p.Arg1217His | missense_variant | 29/30 | ENST00000375663.8 | |
VARS1 | XM_005249362.3 | c.3653G>A | p.Arg1218His | missense_variant | 29/30 | ||
VARS1 | XM_047419296.1 | c.3653G>A | p.Arg1218His | missense_variant | 28/29 | ||
VARS1 | XM_047419297.1 | c.3650G>A | p.Arg1217His | missense_variant | 28/29 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VARS1 | ENST00000375663.8 | c.3650G>A | p.Arg1217His | missense_variant | 29/30 | 1 | NM_006295.3 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000499 AC: 76AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000247 AC: 60AN: 242850Hom.: 0 AF XY: 0.000188 AC XY: 25AN XY: 133090
GnomAD4 exome AF: 0.000106 AC: 155AN: 1460322Hom.: 0 Cov.: 32 AF XY: 0.0000991 AC XY: 72AN XY: 726488
GnomAD4 genome ? AF: 0.000499 AC: 76AN: 152348Hom.: 0 Cov.: 32 AF XY: 0.000510 AC XY: 38AN XY: 74496
ClinVar
Submissions by phenotype
Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy Pathogenic:1Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 04, 2021 | - - |
Likely pathogenic, flagged submission | clinical testing | Baylor Genetics | Feb 13, 2020 | This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Jun 22, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Feb 01, 2021 | The VARS1 c.3650G>A (p.Arg1217His) variant is a missense variant that has been reported in one study in which it was identified in a homozygous state in eight similarly affected individuals from a large consanguineous family and shown to segregate with disease (Alsemari et al. 2017). The proband from the family presented with tonic-clonic seizures from four months of age, with severe developmental delay, including a severe speech impairment, noted from one year of age. Severe growth hormone failure and skeletal abnormalities, including severe osteomalacia and multiple looser zones and fractures, microcephaly, scoliosis, and kyphosis were also noted. Brain MRI showed cerebellar atrophy however cortical abnormalities were not observed. The p.Arg1217His variant is reported at a frequency of 0.002360 in the African /African American population of the Genome Aggregation Database, a frequency that is higher than would be expected for a rare autosomal recessive disease. Homology modelling shows that residue Arg1217 is located within the C-terminal coiled-coil domain of VARS1 and is thought to play a role in the specific recognition of tRNA. The p.Arg1217His variant is predicted to abolish this function (Alsemari et al. 2017). Based on the available evidence and application of the ACMG criteria, the p.Arg1217His variant is classified as a variant of uncertain significance for neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 20, 2022 | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 29137650) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at